Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) — Stella

Recruiting

Back to Smoking Cessation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

The University of Texas Health Science Center, Houston, Houston, Texas

Key details

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~50 participants

Started

June 2022

Primary completion

July 2026

Age range

22 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov